Related Experiment Video
Updated: Dec 20, 2025
05:55
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
7.0K
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor
Carla Eller1, Laura Heydmann1, Che C Colpitts1,2
1Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, F-67000, Strasbourg, France.
Nature Communications
|June 3, 2020
Summary
Researchers discovered CDKN2C, a host factor that enhances Hepatitis B virus (HBV) replication. This finding offers new avenues for developing treatments and understanding HBV infection, a major global health concern.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic Hepatitis B virus (HBV) infection is a leading cause of liver disease and cancer globally.
- Current curative treatments are limited, and understanding virus-host interactions is crucial for developing new therapies.
Purpose of the Study:
- To identify host factors that enhance HBV infection using a genome-wide screen.
- To validate and elucidate the role of identified host factors in HBV replication and pathogenesis.
Main Methods:
- Genome-wide gain-of-function screen in a poorly permissive hepatoma cell line.
- Validation in primary human hepatocytes.
- Mechanistic studies involving cell cycle analysis and gene expression analysis.
Main Results:
- CDKN2C was identified as a key host factor promoting HBV replication.
- CDKN2C is overexpressed in permissive cells and in HBV-infected patients.
- CDKN2C induces G1 cell cycle arrest, upregulating HBV transcription enhancers.
Conclusions:
- CDKN2C is a novel, clinically relevant host factor for HBV.
- This discovery facilitates the development of improved HBV infection models for drug discovery.
- Understanding CDKN2C's role aids in studying the HBV life cycle and disease progression.
